Endogenous Nmnat2 Is an Essential Survival Factor for Maintenance of Healthy Axons

PLoS Biology

Volumn 8, Issue 1, 2010, Pages

  Gilley, Jonathan ^a   Coleman, Michael P ^a  

^a BABRAHAM INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; PROTEASOME; PROTEIN NMNAT2; UNCLASSIFIED DRUG; NICOTINAMIDE NUCLEOTIDE ADENYLYLTRANSFERASE;

ANIMAL CELL; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; ENZYME INHIBITION; GENE SILENCING; HALF LIFE TIME; MOUSE; NERVE DEGENERATION; NERVE FIBER; NERVE FIBER TRANSPORT; NERVE INJURY; NEUROPROTECTION; NONHUMAN; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN METABOLISM; RAT; ANIMAL; C57BL MOUSE; CELL LINE; GENETICS; HUMAN; METABOLISM; NEURITE; PHYSIOLOGY; SPRAGUE DAWLEY RAT; TRANSGENIC RAT; ULTRASTRUCTURE;

WALLERIA;

ANIMALS; AXONS; CELL LINE; HUMANS; MICE; MICE, INBRED C57BL; NERVE DEGENERATION; NEURITES; NICOTINAMIDE-NUCLEOTIDE ADENYLYLTRANSFERASE; RATS; RATS, SPRAGUE-DAWLEY; RATS, TRANSGENIC;

EID: 77954617977     PISSN: 15449173     EISSN: 15457885     Source Type: Journal    
DOI: 10.1371/journal.pbio.1000300     Document Type: Article

References (56)

1. Araki T, Sasaki Y, Milbrandt J, (2004) Increased nuclear NAD biosynthesis and SIRT1 activation prevent axonal degeneration. Science 305: 1010-1013.
2. Avery M. A, Sheehan A. E, Kerr K. S, Wang J, Freeman M. R, (2009) WldS requires Nmnat1 enzymatic activity and N16-VCP interactions to suppress Wallerian degeneration. J Cell Biol 184: 501-513.
3. Beirowski B, Babetto E, Gilley J, Mazzola F, Conforti L, et al.(2009) Non-nuclear WldS determines its neuroprotective efficacy for axons and synapses in vivo. J Neurosci 29: 653-668.
4. Conforti L, Fang G, Beirowski B, Wang M. S, Sorci L, et al.(2007) NAD(+) and axon degeneration revisited: Nmnat1 cannot substitute for WldS to delay Wallerian degeneration. Cell Death Differ 14: 116-127.
5. Conforti L, Wilbrey A, Morreale G, Janeckova L, Beirowski B, et al.(2009) WldS protein requires Nmnat activity and a short N-terminal sequence to protect axons in mice. J Cell Biol 184: 491-500.
6. Mack T. G, Reiner M, Beirowski B, Mi W, Emanuelli M, et al.(2001) Wallerian degeneration of injured axons and synapses is delayed by a Ube4b/Nmnat chimeric gene. Nat Neurosci 4: 1199-1206.
7. Sasaki Y, Vohra B. P, Baloh R. H, Milbrandt J, (2009) Transgenic mice expressing the Nmnat1 protein manifest robust delay in axonal degeneration in vivo. J Neurosci 29: 6526-6534.
8. Yahata N, Yuasa S, Araki T, (2009) Nicotinamide mononucleotide adenylyltransferase expression in mitochondrial matrix delays Wallerian degeneration. J Neurosci 29: 6276-6284.
9. Chevalier-Larsen E, Holzbaur E. L, (2006) Axonal transport and neurodegenerative disease. Biochim Biophys Acta 1762: 1094-1108.
10. Hafezparast M, Klocke R, Ruhrberg C, Marquardt A, Ahmad-Annuar A, et al.(2003) Mutations in dynein link motor neuron degeneration to defects in retrograde transport. Science 300: 808-812.
11. Puls I, Jonnakuty C, LaMonte B. H, Holzbaur E. L, Tokito M, et al.(2003) Mutant dynactin in motor neuron disease. Nat Genet 33: 455-456.
12. Reid E, Kloos M, Ashley-Koch A, Hughes L, Bevan S, et al.(2002) A kinesin heavy chain (KIF5A) mutation in hereditary spastic paraplegia (SPG10). Am J Hum Genet 71: 1189-1194.
13. Zhao C, Takita J, Tanaka Y, Setou M, Nakagawa T, et al.(2001) Charcot-Marie-Tooth disease type 2A caused by mutation in a microtubule motor KIF1Bbeta. Cell 105: 587-597.
14. Lubinska L, (1977) Early course of Wallerian degeneration in myelinated fibres of the rat phrenic nerve. Brain Res 130: 47-63.
15. Beirowski B, Berek L, Adalbert R, Wagner D, Grumme D. S, et al.(2004) Quantitative and qualitative analysis of Wallerian degeneration using restricted axonal labelling in YFP-H mice. J Neurosci Methods 134: 23-35.
16. MacInnis B. L, Campenot R. B, (2005) Regulation of Wallerian degeneration and nerve growth factor withdrawal-induced pruning of axons of sympathetic neurons by the proteasome and the MEK/Erk pathway. Mol Cell Neurosci 28: 430-439.
17. Tsao J. W, George E. B, Griffin J. W, (1999) Temperature modulation reveals three distinct stages of Wallerian degeneration. J Neurosci 19: 4718-4726.
18. Zhai Q, Wang J, Kim A, Liu Q, Watts R, et al.(2003) Involvement of the ubiquitin-proteasome system in the early stages of Wallerian degeneration. Neuron 39: 217-225.
19. Beirowski B, Adalbert R, Wagner D, Grumme D. S, Addicks K, et al.(2005) The progressive nature of Wallerian degeneration in wild-type and slow Wallerian degeneration (WldS) nerves. BMC Neurosci 6: 6.
20. Kerschensteiner M, Schwab M. E, Lichtman J. W, Misgeld T, (2005) In vivo imaging of axonal degeneration and regeneration in the injured spinal cord. Nat Med 11: 572-577.
21. Conforti L, Tarlton A, Mack T. G, Mi W, Buckmaster E. A, et al.(2000) A Ufd2/D4Cole1e chimeric protein and overexpression of Rbp7 in the slow Wallerian degeneration (WldS) mouse. Proc Natl Acad Sci U S A 97: 11377-11382.
22. Emanuelli M, Carnevali F, Saccucci F, Pierella F, Amici A, et al.(2001) Molecular cloning, chromosomal localization, tissue mRNA levels, bacterial expression, and enzymatic properties of human NMN adenylyltransferase. J Biol Chem 276: 406-412.
23. Raffaelli N, Sorci L, Amici A, Emanuelli M, Mazzola F, et al.(2002) Identification of a novel human nicotinamide mononucleotide adenylyltransferase. Biochem Biophys Res Commun 297: 835-840.
24. Zhang X, Kurnasov O. V, Karthikeyan S, Grishin N. V, Osterman A. L, et al.(2003) Structural characterization of a human cytosolic NMN/NaMN adenylyltransferase and implication in human NAD biosynthesis. J Biol Chem 278: 13503-13511.
25. Sasaki Y, Araki T, Milbrandt J, (2006) Stimulation of nicotinamide adenine dinucleotide biosynthetic pathways delays axonal degeneration after axotomy. J Neurosci 26: 8484-8491.
26. Yan T, Feng Y, Zheng J, Ge X, Zhang Y, et al.(2009) Nmnat2 delays axon degeneration in superior cervical ganglia dependent on its NAD synthesis activity. Neurochem Int Epub ahead of print.
27. Ferri A, Sanes J. R, Coleman M. P, Cunningham J. M, Kato A. C, (2003) Inhibiting axon degeneration and synapse loss attenuates apoptosis and disease progression in a mouse model of motoneuron disease. Curr Biol 13: 669-673.
28. Wang M, Wu Y, Culver D. G, Glass J. D, (2001) The gene for slow Wallerian degeneration (WldS) is also protective against vincristine neuropathy. Neurobiol Dis 8: 155-161.
29. Martin D. P, Ito A, Horigome K, Lampe P. A, Johnson E. M Jr, (1992) Biochemical characterization of programmed cell death in NGF-deprived sympathetic neurons. J Neurobiol 23: 1205-1220.
30. Kirkland R. A, Franklin J. L, (2007) Rate of neurite outgrowth in sympathetic neurons is highly resistant to suppression of protein synthesis: role of protein degradation/synthesis coupling. Neurosci Lett 411: 52-55.
31. Estridge M, Bunge R, (1978) Compositional analysis of growing axons from rat sympathetic neurons. J Cell Biol 79: 138-155.
32. Fainzilber M, Twiss J. L, (2006) Tracking in the WldS- the hunting of the SIRT and the luring of the Draper. Neuron 50: 819-821.
33. Eng H, Lund K, Campenot R. B, (1999) Synthesis of beta-tubulin, actin, and other proteins in axons of sympathetic neurons in compartmented cultures. J Neurosci 19: 1-9.
34. Berger F, Lau C, Dahlmann M, Ziegler M, (2005) Subcellular compartmentation and differential catalytic properties of the three human nicotinamide mononucleotide adenylyltransferase isoforms. J Biol Chem 280: 36334-36341.
35. Deckwerth T. L, Johnson E. M, Jr., (1994) Neurites can remain viable after destruction of the neuronal soma by programmed cell death (apoptosis). Dev Biol 165: 63-72.
36. Burne J. F, Staple J. K, Raff M. C, (1996) Glial cells are increased proportionally in transgenic optic nerves with increased numbers of axons. J Neurosci 16: 2064-2073.
37. Finn J. T, Weil M, Archer F, Siman R, Srinivasan A, et al.(2000) Evidence that Wallerian degeneration and localized axon degeneration induced by local neurotrophin deprivation do not involve caspases. J Neurosci 20: 1333-1341.
38. Whitmore A. V, Lindsten T, Raff M. C, Thompson C. B, (2003) The proapoptotic proteins Bax and Bak are not involved in Wallerian degeneration. Cell Death Differ 10: 260-261.
39. Laser H, Mack T. G, Wagner D, Coleman M. P, (2003) Proteasome inhibition arrests neurite outgrowth and causes "dying-back" degeneration in primary culture. J Neurosci Res 74: 906-916.
40. Lunn E. R, Perry V. H, Brown M. C, Rosen H, Gordon S, (1989) Absence of Wallerian degeneration does not hinder regeneration in peripheral nerve. Eur J Neurosci 1: 27-33.
41. Wang M. S, Davis A. A, Culver D. G, Glass J. D, (2002) WldS mice are resistant to paclitaxel (taxol) neuropathy. Ann Neurol 52: 442-447.
42. Merianda T. T, Lin A. C, Lam J. S, Vuppalanchi D, Willis D. E, et al.(2008) A functional equivalent of endoplasmic reticulum and Golgi in axons for secretion of locally synthesized proteins. Mol Cell Neurosci.
43. Sasaki Y, Vohra B. P, Lund F. E, Milbrandt J, (2009) Nicotinamide mononucleotide adenylyl transferase-mediated axonal protection requires enzymatic activity but not increased levels of neuronal nicotinamide adenine dinucleotide. J Neurosci 29: 5525-5535.
44. Suzuki K, Koike T, (2007) Resveratrol abolishes resistance to axonal degeneration in slow Wallerian degeneration (WldS) mice: activation of SIRT2, an NAD-dependent tubulin deacetylase. Biochem Biophys Res Commun 359: 665-671.
45. Wang J, Zhai Q, Chen Y, Lin E, Gu W, et al.(2005) A local mechanism mediates NAD-dependent protection of axon degeneration. J Cell Biol 170: 349-355.
46. Miller B. R, Press C, Daniels R. W, Sasaki Y, Milbrandt J, et al.(2009) A dual leucine kinase-dependent axon self-destruction program promotes Wallerian degeneration. Nat Neurosci 12: 387-389.
47. Spencer M. J, Guyon J. R, Sorimachi H, Potts A, Richard I, et al.(2002) Stable expression of calpain 3 from a muscle transgene in vivo: immature muscle in transgenic mice suggests a role for calpain 3 in muscle maturation. Proc Natl Acad Sci U S A 99: 8874-8879.
48. Zhai R. G, Cao Y, Hiesinger P. R, Zhou Y, Mehta S. Q, et al.(2006) Drosophila NMNAT maintains neural integrity independent of its NAD synthesis activity. PLoS Biol 4: e416 doi:10.1371/journal.pbio.0040416.
49. Zhai R. G, Zhang F, Hiesinger P. R, Cao Y, Haueter C. M, et al.(2008) NAD synthase NMNAT acts as a chaperone to protect against neurodegeneration. Nature 452: 887-891.
50. De Vos K. J, Grierson A. J, Ackerley S, Miller C. C, (2008) Role of axonal transport in neurodegenerative diseases. Annu Rev Neurosci 31: 151-173.
51. Minoshima S, Cross D, (2008) In vivo imaging of axonal transport using MRI: aging and Alzheimer's disease. Eur J Nucl Med Mol Imaging 35 (Suppl 1): S89-S92.
52. Wong M. L, Yen Y. R, (1998) Protein synthesis in pseudorabies virus-infected cells: decreased expression of protein kinase PKR, and effects of 2-aminopurine and adenine. Virus Res 56: 199-206.
53. Bendotti C, Calvaresi N, Chiveri L, Prelle A, Moggio M, et al.(2001) Early vacuolization and mitochondrial damage in motor neurons of FALS mice are not associated with apoptosis or with changes in cytochrome oxidase histochemical reactivity. J Neurol Sci 191: 25-33.
54. Fischer L. R, Culver D. G, Davis A. A, Tennant P, Wang M, et al.(2005) The WldS gene modestly prolongs survival in the SOD1G93A fALS mouse. Neurobiol Dis 19: 293-300.
55. Campenot R. B, (1992) Construction and use of compartmented cultures. pp. 53-63 Protocols for Neural Cell Culture: Humana Press Inc.
56. Adalbert R, Gillingwater T. H, Haley J. E, Bridge K, Beirowski B, et al.(2005) A rat model of slow Wallerian degeneration (WldS) with improved preservation of neuromuscular synapses. Eur J Neurosci 21: 271-277.